Ameren (NYSE:AEE) Announces FY 2027 Earnings Guidance

Ameren (NYSE:AEE) updated its FY 2027 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 5.700-5.900 for the period, compared to the consensus earnings per share estimate of 5.810.

Ameren Trading Up 1.2%

AEE traded up $1.32 during mid-day trading on Monday, reaching $114.17. The stock had a trading volume of 2,276,289 shares, compared to its average volume of 1,748,497. The stock has a market capitalization of $31.61 billion, a P/E ratio of 19.86, a P/E/G ratio of 3.29 and a beta of 0.42. The company has a debt-to-equity ratio of 1.43, a quick ratio of 0.54 and a current ratio of 0.74. The firm’s fifty day simple moving average is $104.89 and its two-hundred day simple moving average is $108.51. Ameren has a 52 week low of $96.57 and a 52 week high of $118.32.

Ameren (NYSE:AEE) last released its earnings results on Thursday, November 5th. The utilities provider reported $2.42 earnings per share for the quarter, topping analysts’ consensus estimates of $2.29 by $0.13. The company had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.82 billion. Ameren had a return on equity of 11.27% and a net margin of 17.90%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.17 earnings per share. On average, equities analysts predict that Ameren will post 5.41 EPS for the current year.

Ameren Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 31st. Shareholders of record on Tuesday, December 8th will be issued a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 2.6%. The ex-dividend date of this dividend is Tuesday, December 8th. Ameren’s payout ratio is currently 52.17%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Morgan Stanley upped their target price on shares of Ameren from $108.00 to $109.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 21st. Weiss Ratings reiterated a “buy (b)” rating on shares of Ameren in a research report on Wednesday. Scotiabank assumed coverage on shares of Ameren in a research report on Tuesday, September 29th. They set a “sector perform” rating and a $104.00 price target for the company. HSBC initiated coverage on shares of Ameren in a research note on Thursday, October 22nd. They set a “buy” rating and a $119.10 price target for the company. Finally, Truist Financial cut their price objective on shares of Ameren from $120.00 to $116.00 and set a “buy” rating on the stock in a report on Wednesday, October 14th. Thirteen analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat.com, Ameren currently has an average rating of “Moderate Buy” and an average price target of $117.95.

Insider Buying and Selling

In related news, SVP Theresa Shaw sold 325 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $108.93, for a total value of $35,402.25. Following the completion of the transaction, the senior vice president directly owned 32,340 shares of the company’s stock, valued at approximately $3,522,796.20. This represents a 0.99% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael Moehn sold 6,500 shares of the stock in a transaction dated Tuesday, November 3rd. The stock was sold at an average price of $110.72, for a total value of $719,680.00. Following the transaction, the insider owned 193,790 shares of the company’s stock, valued at approximately $21,456,428.80. This trade represents a 3.25% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 7,073 shares of company stock valued at $781,254. 0.29% of the stock is owned by corporate insiders.

Ameren Company Profile